EAM
ELV icon

Eagle Asset Management’s Elevance Health ELV Stock Holding History

Eagle Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,784
Closed -$3.09M – 550
2024
Q2 		$3.09M Buy
5,784
+203
+4% +$107K 0.02% 436
2024
Q1 		$2.88M Buy
+5,581
New +$2.78M 0.01% 441
2022
Q1 		– Sell
-845
Closed -$394K – 590
2021
Q4 		$394K Sell
845
-512
-38% -$215K ﹤0.01% 567
2021
Q3 		$505K Sell
1,357
-380
-22% -$144K ﹤0.01% 550
2021
Q2 		$663K Sell
1,737
-47
-3% -$18K ﹤0.01% 531
2021
Q1 		$631K Buy
1,784
+698
+64% +$224K ﹤0.01% 530
2020
Q4 		$348K Sell
1,086
-6,086
-85% -$1.87M ﹤0.01% 483
2020
Q3 		$1.86M Sell
7,172
-205
-3% -$55.2K 0.01% 447
2020
Q2 		$1.91M Sell
7,377
-437
-6% -$117K 0.01% 450
2020
Q1 		$1.77M Sell
7,814
-6,615
-46% -$1.8M 0.01% 477
2019
Q4 		$4.36M Sell
14,429
-2,859
-17% -$787K 0.02% 426
2019
Q3 		$4.15M Sell
17,288
-760
-4% -$208K 0.02% 430
2019
Q2 		$5.09M Sell
18,048
-7,634
-30% -$2.09M 0.03% 401
2019
Q1 		$7.37M Sell
25,682
-472
-2% -$137K 0.04% 348
2018
Q4 		$6.87M Buy
26,154
+13,826
+112% +$3.8M 0.04% 334
2018
Q3 		$3.38M Buy
12,328
+4,679
+61% +$1.21M 0.02% 471
2018
Q2 		$1.82M Sell
7,649
-76
-1% -$17.6K 0.01% 528
2018
Q1 		$1.7M Buy
+7,725
New +$1.81M 0.01% 545
2016
Q3 		– Sell
-23,063
Closed -$3.03M – 639
2016
Q2 		$3.03M Sell
23,063
-264
-1% -$36.1K 0.02% 490
2016
Q1 		$3.24M Sell
23,327
-184
-0.8% -$24.6K 0.02% 478
2015
Q4 		$3.28M Sell
23,511
-151
-0.6% -$20.8K 0.02% 481
2015
Q3 		$3.31M Sell
23,662
-1,973
-8% -$297K 0.02% 479
2015
Q2 		$4.21M Sell
25,635
-313
-1% -$50K 0.02% 464
2015
Q1 		$4.01M Buy
25,948
+8,403
+48% +$1.2M 0.02% 455
2014
Q4 		$2.2M Sell
17,545
-8,798
-33% -$1.09M 0.01% 536
2014
Q3 		$3.15M Buy
+26,343
New +$3.02M 0.02% 509

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Eagle Asset Management's ELV Position: Q3 2024 in Review

Eagle Asset Management sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 5,784 shares — an estimated $3.09M sold.

Eagle Asset Management first reported a position in ELV in Q3 2014 and held it in 26 quarters. The position peaked at $7.37M in Q1 2019. 1,698 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Eagle Asset Management reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Eagle Asset Management sold 5,784 Elevance Health shares in Q3 2024, an estimated $3.09M.
  • Eagle Asset Management first reported a position in Elevance Health in Q3 2014 and held it in 26 quarters.
  • Eagle Asset Management's Elevance Health position peaked at $7.37M in Q1 2019.
  • 1,698 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.